Veera Ganesh Yerra

Dr. Veera Ganesh Yerra

Keenan Research Center for Biomedical Sciences
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Redox Biology
Verified
Journal Article
Open access
AAAparna Areti
Aparna Areti
VYVeera Ganesh Yerra
Veera Ganesh Yerra
VNVGM Naidu
VGM Naidu
AKAshutosh Kumar
Ashutosh Kumar
Peripheral neuropathy is a severe dose limiting toxicity associated with cancer chemotherapy. Ever since it was identified, the clear pathological mechanisms underlying chemotherapy induced peripheral neuropathy (CIPN) remain sparse and considerable involvement of oxidative stress and neuroinflammation has been realized recently. Despite the empirical use of antioxidants in the therapy of CIPN, the oxidative stress mediated neuronal damage in peripheral neuropathy is still debatable. The current review focuses on nerve damage due to oxidative stress and mitochondrial dysfunction as key pathogenic mechanisms involved in CIPN. Oxidative stress as a central mediator of apoptosis, neuroinflammation, metabolic disturbances and bioenergetic failure in neurons has been highlighted in this review along with a summary of research on dietary antioxidants and other nutraceuticals which have undergone prospective controlled clinical trials in patients undergoing chemotherapy.

1 January 2013 in Redox Biology
Verified
Journal Article
Open access
VYVeera Ganesh Yerra
Veera Ganesh Yerra
GNGeeta Negi
Geeta Negi
SSShyam S Sharma
Shyam S Sharma
AKAshutosh Kumar
Ashutosh Kumar
The Nuclear factor-2 erythroid related factor-2 (Nrf2) is a redox regulated transcription factor involved in the regulation of antioxidant defence systems. It drives the production of endogenous antioxidant defences and detoxifying enzymes. Nuclear factor-kappa light chain enhancer of B cells (NF-κB) is a transcription factor, involved in proinflammatory cytokine production, in addition to its immunological function. Both Nrf2 and NF-κB regulation are co-ordinated in order to maintain redox homeostasis in healthy cells. However, during pathological conditions this regulation is perturbed offering an opportunity for therapeutic intervention. Diabetic neuropathy is a condition, in which change in expression pattern of Nrf2 and NF-κB has been reported. This review aims to focus on the role of the Nrf2 and NF-κB in diabetic neuropathy and summarizes the therapeutic outcomes of various pharmacological modulators targeted at the Nrf2-NF-κB axis in diabetic neuropathy.

30 April 2014 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
RSReddemma Sandireddy
Reddemma Sandireddy
VYVeera Ganesh Yerra
Veera Ganesh Yerra
AAAparna Areti
Aparna Areti
PKPrashanth Komirishetty
Prashanth Komirishetty
AKAshutosh Kumar
Ashutosh Kumar
In Diabetes, the chronic hyperglycemia and associated complications affecting peripheral nerves are one of the most commonly occurring microvascular complications with an overall prevalence of 50–60%. Among the vascular complications of diabetes, diabetic neuropathy is the most painful and disabling, fatal complication affecting the quality of life in patients. Several theories of etiologies surfaced down the lane, amongst which the oxidative stress mediated damage in neurons and surrounding glial cell has gained attention as one of the vital mechanisms in the pathogenesis of neuropathy. Mitochondria induced ROS and other oxidants are responsible for altering the balance between oxidants and innate antioxidant defence of the body. Oxidative-nitrosative stress not only activates the major pathways namely, polyol pathway flux, advanced glycation end products formation, activation of protein kinase C, and overactivity of the hexosamine pathway, but also initiates and amplifies neuroinflammation. The cross talk between oxidative stress and inflammation is due to the activation of NF-κB and AP-1 and inhibition of Nrf2, peroxynitrite mediate endothelial dysfunction, altered NO levels, and macrophage migration. These all culminate in the production of proinflammatory cytokines which are responsible for nerve tissue damage and debilitating neuropathies. This review focuses on the relationship between oxidative stress and neuroinflammation in the development and progression of diabetic neuropathy.

1 September 2017 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
VYVeera Ganesh Yerra
Veera Ganesh Yerra
AKAnil Kumar Kalvala
Anil Kumar Kalvala
AKAshutosh Kumar
Ashutosh Kumar

23 October 2019 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YMY. V. Madhavi
Y. V. Madhavi
NGNikhil Gaikwad
Nikhil Gaikwad
VYVeera Ganesh Yerra
Veera Ganesh Yerra
AKAnil Kumar Kalvala
Anil Kumar Kalvala
SNSrinivas Nanduri
Srinivas Nanduri
AKAshutosh Kumar
Ashutosh Kumar
Adenosine 5′-monophosphate activated protein kinase (AMPK) is a key enzymatic protein involved in linking the energy sensing to the metabolic manipulation. It is a serine/threonine kinase activated by several upstream kinases. AMPK is a heterotrimeric protein complex regulated by AMP, ADP, and ATP allosterically. AMPK is ubiquitously expressed in various tissues of the living system such as heart, kidney, liver, brain and skeletal muscles. Thus malfunctioning of AMPK is expected to harbor several human pathologies especially diseases associated with metabolic and mitochondrial dysfunction. AMPK activators including synthetic derivatives and several natural products that have been found to show therapeutic relief in several animal models of disease. AMP, 5-Aminoimidazole-4-carboxamide riboside (AICA riboside) and A769662 are important activators of AMPK which have potential therapeutic importance in diabetes and diabetic complications. AMPK modulation has shown beneficial effects against diabetes, cardiovascular complications and diabetic neuropathy. The major impact of AMPK modulation ensures healthy functioning of mitochondria and energy homeostasis in addition to maintaining a strict check on inflammatory processes, autophagy and apoptosis. Structural studies on AMP and AICAR suggest that the free amino group is imperative for AMPK stimulation. A769662, a non-nucleoside thienopyridone compound which resulted from the lead optimization studies on A-592107 and several other related compound is reported to exhibit a promising effect on diabetes and its complications through activation of AMPK. Subsequent to the discovery of A769662, several thienopyridones, hydroxybiphenyls pyrrolopyridones have been reported as AMPK modulators. The review will explore the structure-function relationships of these analogues and the prospect of targeting AMPK in diabetes and diabetic complications.

23 September 2015 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
RSReddemma Sandireddy
Reddemma Sandireddy
VYVeera Ganesh Yerra
Veera Ganesh Yerra
PKPrashanth Komirishetti
Prashanth Komirishetti
AAAparna Areti
Aparna Areti
AKAshutosh Kumar
Ashutosh Kumar